The silent epidemic of undiagnosed COPD

  • 7 min read
  • by IQAir Staff Writers
The silent epidemic of undiagnosed COPD

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, claiming approximately 3.4 million lives in 2023 alone (1).

COPD is a progressive lung condition that makes it increasingly difficult to breathe. Despite its widespread impact, COPD often goes undetected until breathing problems become difficult to ignore. Early symptoms of COPD are often dismissed as normal aging, fatigue, or the effects of smoking, allowing the disease to progress without proper treatment.

Early diagnosis can make a meaningful difference in managing COPD and protecting long-term lung function. By recognizing warning signs, understanding environmental risk factors, and seeking appropriate testing, individuals can take steps to slow disease progression and improve their quality of life.

What is chronic obstructive pulmonary disease (COPD)?

Chronic obstructive pulmonary disease (COPD) encompasses a group of progressive lung conditions. The disease develops when the airways become narrowed or the tiny air sacs in the lungs become damaged, reducing the amount of air that can move in and out of the lungs.

COPD is not a single disease. Two of the most common types are (2):

  • Chronic bronchitis: Long-term inflammation of the airways that causes persistent coughing and excess mucus production.
  • Emphysema: Damage to the tiny air sacs in the lungs, reducing their ability to transfer oxygen into the bloodstream.

Common COPD symptoms include:

  • Shortness of breath, especially during physical activity
  • Persistent coughing
  • Excess mucus production
  • Wheezing or chest tightness
  • Frequent respiratory infections
  • Fatigue and reduced exercise tolerance

Although COPD has no cure, it is preventable and treatable. Early medical intervention can help manage symptoms, reduce complications, and slow the progression of lung damage.

According to the World Health Organization (WHO), COPD cases accounted for about 6% of all deaths worldwide in 2023. However, nearly 90% of COPD deaths among people younger than 70 occur in low- and middle-income countries.

Despite these numbers, COPD remains widely underdiagnosed. Individuals can live with symptoms for years without realizing they have a progressive respiratory condition.

Why COPD often goes undiagnosed

One of the biggest challenges in COPD treatment is recognizing the disease before significant lung damage occurs. Unlike some respiratory illnesses that develop suddenly, COPD symptoms often appear gradually and worsen over several years.

Research suggests that approximately 70% of COPD cases worldwide may remain undiagnosed, although rates vary considerably between populations and healthcare systems (3). Limited access to diagnostic testing and a lack of awareness among patients and healthcare providers can contribute to underdiagnosis.

The primary diagnostic test for COPD is spirometry, a breathing test that measures how much air a person can exhale and how quickly they can do so. The test helps identify persistent airflow obstruction and distinguish COPD from other respiratory conditions.

However, spirometry is not consistently available in primary care settings, particularly in low- and middle-income countries. Without objective testing, patients may receive an incorrect diagnosis or treatment that does not address the underlying condition.

Individuals over 40 who experience persistent respiratory symptoms should discuss COPD testing with a healthcare provider, particularly if they have a history of:

  • Smoking or secondhand smoke exposure
  • Long-term exposure to outdoor air pollution
  • Household exposure to cooking smoke
  • Occupational exposure to dust, chemicals, or fumes
  • Repeated respiratory infections

Recognizing these warning signs and requesting appropriate testing can help identify COPD before symptoms become severe. While smoking is a major risk factor, exposure to air pollution, household smoke, and workplace chemicals also contributes to the disease. These environmental exposures can affect people who have never smoked, making COPD a broader public health concern than many realize.

What causes COPD?

Smoking is one of the most recognized causes of COPD, but it is not the only contributor. Long-term exposure to airborne pollutants and other respiratory irritants can also damage lung tissue and contribute to the development of the disease.

In high-income countries, tobacco smoking accounts for more than 70% of COPD cases. In low- and middle-income countries, however, smoking accounts for approximately 30–40% of cases, highlighting the significant role of environmental exposures.

Some of the most common environmental risk factors include:

  • Household air pollution: Burning wood, coal, charcoal, and other biomass fuels for cooking or heating can release harmful particles into indoor air.
  • Outdoor air pollution: Fine particulate matter (PM2.5), traffic emissions, and industrial pollutants can penetrate deep into the lungs and contribute to chronic inflammation and respiratory damage.
  • Occupational exposure: Dust, chemical fumes, and industrial emissions can increase COPD risk among workers in construction, manufacturing, mining, and agriculture.
  • Secondhand smoke: Regular exposure to tobacco smoke can damage the respiratory system even among people who do not smoke themselves.

Particulate matter pollution is a growing concern for COPD cases. A Global Burden of Disease analysis found that particulate matter pollution accounted for approximately 41.7% of global COPD-related disability-adjusted life years (DALYs) in 2021, making it the leading attributable risk factor in that analysis (4).

The global burden could continue to grow. A 2023 study projected that COPD cases could approach 600 million worldwide by 2050, representing a 23% increase compared with 2020 (5).

How early COPD diagnosis can improve long-term health

COPD causes progressive lung damage, making early recognition especially impactful for symptom relief and rehabilitation. Although existing lung damage cannot be reversed, treatment and lifestyle changes can help patients manage symptoms and preserve their remaining lung function. Early diagnosis provides several meaningful benefits for COPD treatment, including:

  • Slower disease progression: Reducing exposure to respiratory irritants and following prescribed treatment can help limit further lung damage.
  • Improved breathing: Bronchodilator medications relax the muscles surrounding the airways, making it easier for patients to breathe.
  • Fewer exacerbations: Vaccinations and appropriate medical management can help reduce respiratory infections and episodes of worsening symptoms.
  • Better physical function: Pulmonary rehabilitation programs help patients improve exercise tolerance, breathing techniques, and overall physical conditioning.
  • Improved quality of life: Recognizing COPD earlier gives patients more opportunities to manage symptoms and maintain everyday activities.

COPD can also have origins much earlier in life. Poor lung development during pregnancy, childhood respiratory infections, and certain genetic conditions can affect lung function and increase the likelihood of developing COPD later in life.

COPD can begin long before the first symptoms. Prevention and regular respiratory check-ups play a key role.

How to prevent COPD and protect lung health

Preventing COPD relies on reducing exposure to harmful respiratory irritants and improving access to clean air. While not every case can be prevented, there are meaningful steps that can be taken to reduce risk.

Daily habits and environmental changes can help limit exposure to pollutants that contribute to respiratory damage. Some practical prevention strategies include:

  • Avoid secondhand smoke and tobacco exposure.
  • Maximize ventilation indoors when cooking or cleaning.
  • Monitor local air quality levels and PM2.5 concentrations, particularly during periods of elevated pollution.
  • Limit strenuous outdoor activity when air quality is unhealthy.
  • Use face masks when working around dust, fumes, and chemicals.
  • Maintain healthy indoor air quality through proper source control and ultrafine air filtration.
  • Take prescribed medications and recommended healthcare instructions if diagnosed with COPD.

Conclusion

Chronic obstructive pulmonary disease is a common but frequently overlooked respiratory disease that can significantly affect long-term health and quality of life. Although smoking remains a major risk factor, air pollution, household smoke, and occupational exposures also contribute to its growing global burden.

As air pollution continues to threaten respiratory health worldwide, protecting lung function requires more than treating symptoms. Reducing exposure to harmful pollutants, improving access to diagnostic testing, and promoting awareness of early warning signs can help individuals and communities take a more proactive approach to COPD management.

This November 18, contribute to World COPD Day through meaningful actions that can improve community awareness or personal well-being. Healthy lungs depend on healthy air, and protecting respiratory health starts long before breathing becomes difficult.

About IQAir

IQAir is a Swiss technology company that empowers individuals, organizations and governments to improve air quality through information and collaboration.

Article resources

[1] World Health Organization. (2026, June 10). Chronic obstructive pulmonary disease (COPD). 

[2] Stanford Health Care. (2017, September 11). Types of chronic obstructive pulmonary disease. 

[3] Diab N, Gershon A, Sin D, et al. (2018, November 1). Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. American Journal
of Respiratory and Critical Care Medicine. DOI:10.1164/rccm.201804-0621CI. 

[4] Cao Z, Tong X, He L, et al. (2026, January 13). Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2021: results from the Global Burden of Disease Study 2021. BMJ Public Health. DOI:10.1136/bmjph-2024-002489. 

[5] Boers E, Barrett M, Su JG, et al. (2023, December 7). Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Network Open. DOI:10.1001/jamanetworkopen.2023.46598. 

Newsletter

Get exclusive articles, product updates, tips, and occasional offers delivered to your inbox. You can unsubscribe at any time.

Read about our privacy policy

Featured products
AirVisual Pro Indoor Monitor
Indoor air quality monitor reports air quality inside your home, school, or business.
AirVisual Outdoor Monitor
Ultimate outdoor air quality monitor with hyper-local, real-time air quality surrounding your home, school, or business.